SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences - Quaterly Results

14 Feb 2025 Evaluate
The revenue zoomed 10.49% to Rs. 2050.71 millions for the quarter ended December 2024 as compared to Rs. 1856.07 millions during the corresponding quarter last year.The Net Loss for the quarter ended December 2024 is Rs. -56.26 millions as compared to Net Loss of Rs. -116.40 millions of corresponding quarter ended December 2023Operating Profit saw a handsome growth to 232.13 millions from 80.14 millions in the quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 2050.71 1856.07 10.49 6138.95 5529.33 11.03 7732.62 7894.36 -2.05
Other Income 68.17 21.26 220.65 116.78 137.72 -15.20 188.83 288.32 -34.51
PBIDT 232.13 80.14 189.66 490.11 661.07 -25.86 460.13 1563.90 -70.58
Interest 171.45 133.01 28.90 486.80 404.50 20.35 543.26 569.42 -4.59
PBDT 60.68 -52.87 -214.77 -959.36 256.57 -473.92 -102.41 994.48 -110.30
Depreciation 132.62 124.01 6.94 393.91 366.07 7.61 493.90 328.21 50.48
PBT -71.94 -176.88 -59.33 -1353.27 -109.50 1135.86 -596.31 666.27 -189.50
TAX -15.68 -60.48 -74.07 -433.99 -36.34 1094.25 -82.43 190.71 -143.22
Deferred Tax -15.68 -47.17 -66.76 -450.59 -42.62 957.23 -82.43 51.51 -260.03
PAT -56.26 -116.40 -51.67 -919.28 -73.16 1156.53 -513.88 475.56 -208.06
Equity 167.50 167.46 0.02 167.50 167.46 0.02 167.47 157.09 6.61
PBIDTM(%) 11.32 4.32 162.17 7.98 11.96 -33.22 5.95 19.81 -69.96

Camlin Fine Sciences Share Price

131.85 4.88 (3.84%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×